LARUSSA, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 966
EU - Europa 654
AS - Asia 513
SA - Sud America 27
OC - Oceania 11
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.183
Nazione #
US - Stati Uniti d'America 915
SG - Singapore 282
IT - Italia 225
DE - Germania 129
CN - Cina 104
GB - Regno Unito 95
FI - Finlandia 65
SE - Svezia 55
CA - Canada 41
IR - Iran 38
IN - India 37
NL - Olanda 24
BR - Brasile 22
TR - Turchia 12
TW - Taiwan 11
AU - Australia 10
RU - Federazione Russa 10
HK - Hong Kong 7
FR - Francia 6
MX - Messico 6
PL - Polonia 6
RO - Romania 6
UA - Ucraina 6
ES - Italia 5
EU - Europa 4
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
IL - Israele 3
JP - Giappone 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BE - Belgio 2
CH - Svizzera 2
CU - Cuba 2
EG - Egitto 2
HU - Ungheria 2
IQ - Iraq 2
LT - Lituania 2
PK - Pakistan 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
UY - Uruguay 1
Totale 2.183
Città #
Chandler 152
Singapore 119
Munich 110
Chicago 89
London 85
Santa Clara 79
Lawrence 68
Princeton 68
Milan 66
Helsinki 46
Wilmington 41
Ashburn 34
Ottawa 30
Catanzaro 28
Des Moines 21
Redwood City 19
Mumbai 17
Mendicino 12
Shanghai 11
Turku 11
Beijing 10
Guangzhou 10
Praia A Mare 9
Collegeville 7
Phoenix 7
Pune 7
Rome 7
Tehran 7
Cittanova 6
Los Angeles 6
Redmond 6
The Dalles 6
Boardman 5
Hanover 5
Hong Kong 5
Istanbul 5
Jyväskylä 5
Norwalk 5
Shenzhen 5
Brooklyn 4
Clearwater 4
Horia 4
Montreal 4
San Francisco 4
Selargius 4
São Paulo 4
Taipei 4
Bade District 3
Bari 3
Benevento 3
Bratislava 3
Chennai 3
Jiaxing 3
Kahramanmaraş 3
Miguel Hidalgo 3
Nanjing 3
Naples 3
New York 3
Paris 3
Rende 3
Rio de Janeiro 3
Wuxi 3
Zabki 3
Ann Arbor 2
Atlanta 2
Bungarribee 2
Calumpit 2
Cape Town 2
Capurso 2
Castel Campagnano 2
Charlotte 2
Chelsea 2
Columbus 2
Dallas 2
Esslingen am Neckar 2
Frankfurt am Main 2
Fremont 2
Havana 2
Hefei 2
Karachi 2
Leuven 2
Lyon 2
Miami 2
New Taipei City 2
Palermo 2
Pasargad 2
Pécs 2
Riyadh 2
San Nicola Manfredi 2
Shenyang 2
Silea 2
St Petersburg 2
Stockholm 2
Tokyo 2
Toronto 2
Vienna 2
Wanchai 2
Warsaw 2
Xi'an 2
Zhengzhou 2
Totale 1.383
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 210
Dietary polyphenolsand non-alcoholic fatty liver disease 73
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 57
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 55
The role of gluten-free diet in nonalcoholic fatty liver disease development 53
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 50
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 49
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 45
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 45
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 44
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 43
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 41
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 41
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 40
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 39
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 37
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 37
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 35
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 35
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 35
Bone mineralization in celiac disease 34
Gut microbiota and non-alcoholic fatty liver disease 34
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 33
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 33
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 32
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 31
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 30
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 30
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 30
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 29
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 28
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 27
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 27
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 27
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 27
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 26
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 26
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 26
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 26
Crohn disease: Identification, diagnosis, and clinical management. 26
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 25
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 25
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 25
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 25
Liver Cirrhosis Complications Management At The Emergency Department 24
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 23
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 23
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 22
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 21
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 20
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 19
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 19
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 19
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 19
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 19
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 19
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 18
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 18
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 17
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 17
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 17
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 16
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 16
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 16
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 15
Liver steatosis in celiac disease: the open door 15
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 15
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 15
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 14
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 14
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 13
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 13
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 12
Potential role of nutraceutical compounds in inflammatory bowel disease 11
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 11
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 11
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 10
Totale 2.297
Categoria #
all - tutte 29.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 9 8 2 16 17 13 10 19 32 7 2 0
2021/2022258 8 7 14 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024290 69 20 25 16 10 75 6 15 27 2 9 16
2024/2025884 119 45 43 18 70 121 64 42 159 8 73 122
2025/20263 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.297